Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Part of paid clinical trials in Charlotte, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT06567704
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Interviews — BEHAVIORAL
    Interviews

Study Details

The purpose of this research is to understand cancer related fatigue in patients with non-small cell lung cancer (NSCLC), who are being treated with an immune checkpoint inhibitor.

Key Dates

Start date
Mar 26, 2025
Status verified
Jan 2026
Primary completion
Aug 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
20 participants (estimated)

Arms

  • Arm: Non-small cell lung cancer (NSCLC)
    Non-small cell lung cancer (NSCLC) patients treated with with immune checkpoint inhibitor.

Primary Outcome Measure

Themes from qualitative interviews with patients [ Time Frame: At 3 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Atrium Health Levine CancerCharlotteNorth Carolina28204
Megan Lattanze
[email protected]
(980) 442-4239
Dori Beeler, PhD (PRINCIPAL_INVESTIGATOR)
Wake Forest Baptist Comprehensive Cancer CenterWinston-SalemNorth Carolina27157
Dori Beeler, PhD
[email protected]
980-442-7883
Dori Beeler (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charlotte, NC

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Atrium Health Levine Cancer· Charlotte, NCWake Forest Baptist Comprehensive Cancer Center· Winston-Salem, NC

Related Studies